Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
Neurology|September 17, 1999
A pilot study of MRI activity before and during interferon beta-1a therapyE Waubant, D E Goodkin, R Sloan, et al.Archives of Neurology|September 17, 1999
Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disabilityP B Andersson, E Waubant, L Gee, et al.Journal of the Neurological Sciences|November 6, 1998
Glucocorticosteroid therapy for multiple sclerosis: a critical reviewP B Andersson, D E GoodkinBailliere'S Clinical Neurology|April 2, 1999
Outcome measures in multiple sclerosis clinical trialsP B Andersson, D E GoodkinThe Western Journal of Medicine|November 1, 1996
Current pharmacologic treatment of multiple sclerosis symptomsP B Andersson, D E GoodkinNeurology|October 26, 1999
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosisE Waubant, D E Goodkin, L Gee, et al.Revue Neurologique|June 15, 1999
[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis]E Waubant, R Sloan, P B Andersson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MSJ Suhy, W D Rooney, D E Goodkin, et al.Neurology|May 10, 2000
Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1aM Kita, D E Goodkin, P Bacchetti, et al.The Western Journal of Medicine|September 1, 1994
Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosisD E GoodkinPageof 14